MOUNT LAUREL, N.J.,
Feb. 18, 2021 /PRNewswire/ --
RhythMedix, a leader in remote cardiac monitoring, today announced
the release of its next-generation RhythmStar® wearable
device with built-in 4G cellular connectivity. The novel cardiac
telemetry monitor is discreetly worn for extended remote monitoring
without the need for an additional phone or communication device.
The technology enables rapid ECG analysis and reporting of cardiac
abnormalities by RhythMedix's team of US-based certified
technicians, who alert physicians if an arrhythmia of concern is
detected. RhythmStar is now available with HeartTime™ on-demand
telemetry mode, an innovative platform that allows physicians to
evaluate cardiac activity and expedite care via a telemedicine
appointment, limiting the need for an in-person office visit.
Heart arrhythmias are a major health concern that doubles the
risk of death in an estimated 33.5 million people
worldwide.1,2 While remote cardiac monitoring has
improved arrhythmia detection, patient compliance and timely access
to heart activity currently limit accurate and timely
diagnosis.
"The novel wearable RhythmStar monitoring device offers
increased patient compliance and allows for accurate assessment of
cardiac rhythm in real time," states Steven
DaTorre, M.D., a Clinical Cardiologist at Cooper University
Health Care in New Jersey. "It
also allows me to remain connected to my patients throughout their
monitoring period, which may expedite a life-saving
diagnosis."
The sleek, one-piece device, with built-in 4G cellular
technology, is the first wearable multi-modality cardiac monitor
(Holter, Event and MCT) that connects patients and clinicians for
improved patient care. RhythmStar integrates seamlessly into
clinical practice, helping physicians make informed treatment
decisions that allow patients to enjoy life, without missing a
beat.
"We are excited to offer physicians and their patients our
unique monitoring solution that improves patient compliance, helps
accelerate diagnosis, and allows physicians to stay virtually
connected to their patients with on-demand access to clinical
data", stated Brian Pike, President,
Chief Operations Officer and Co-Founder of RhythMedix. "We look
forward to bringing this next-generation RhythmStar technology to
physicians across the U.S. in 2021."
About RhythMedix
RhythMedix®, a privately owned
medical device manufacturer, provides innovative technology to
transform the medical monitoring industry and improve patient
outcomes.
Learn more at www.rhythmedix.com.
1.
https://www.ajconline.org/article/S0002-9149(98)00583-9/fulltext
2.
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.113.005119
View original content to download
multimedia:http://www.prnewswire.com/news-releases/rhythmedix-launches-next-generation-rhythmstar-device-the-first-and-only-wearable-cardiac-monitor-with-built-in-cellular-connectivity-301230601.html
SOURCE RhythMedix